Federal Register: FDA Confirms RASUVO Solution Was Not Withdrawn for Safety or Efficacy Reasons
July 22, 2026
July 22, 2026
WASHINGTON, July 22 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) has determined that RASUVO solution, 27.5 milligrams (mg)/0.55 milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for RASUVO solution, 27.5 mg/0.5 . . .
* * *
The Food and Drug Administration (FDA) has determined that RASUVO solution, 27.5 milligrams (mg)/0.55 milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for RASUVO solution, 27.5 mg/0.5 . . .